Individuals, with combined NAT1 rapid and NAT2 slow genotype seemed to have significantly elevated adenocarcinoma risk [16], or the NAT2 slow genotype when combined with the GSTM1 null genotype may confer increased susceptibility to adduct formation, gene mutation and lung cancer when the smoking dose is low [35]. Here, NAT2 is linked to adenocarcinoma.